A Polyclonal Antibody Based Immunoassay Detects Seven Subtypes of Shiga Toxin 2 Produced by Escherichia coli in Human and Environmental Samples

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  He, Xiaohua ^a   Patfield, Stephanie ^a   Hnasko, Robert ^a   Rasooly, Reuven ^a   Mandrell, Robert E ^a  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; POLYCLONAL ANTIBODY; VEROTOXIN 2;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOSYNTHESIS; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FECES ANALYSIS; HUMAN; LIMIT OF DETECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROCESS DEVELOPMENT; REAL TIME POLYMERASE CHAIN REACTION; SANDWHICH ENZYME LINKED IMMUNOSORBENT ASSAY; SENSITIVITY AND SPECIFICITY; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SOIL ANALYSIS; TOXIN ANALYSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; CERCOPITHECUS AETHIOPS; ENVIRONMENTAL MICROBIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMANS; IMMUNE SERA; IMMUNIZATION; IMMUNOASSAY; IMMUNOGLOBULIN G; NEUTRALIZATION TESTS; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; VERO CELLS; WATER MICROBIOLOGY;

EID: 84885709883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076368     Document Type: Article

References (29)

1. Karch H, Tarr PI, Bielaszewska M, (2005) Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295: 405-418.
2. Manning SD, Madera RT, Schneider W, Dietrich SE, Khalife W, et al. (2007) Surveillance for Shiga toxin-producing Escherichia coli, Michigan, 2001-2005. Emerg Infect Dis 13: 318-321.
3. Fremaux B, Prigent-Combaret C, Vernozy-Rozand C, (2008) Long-term survival of Shiga toxin-producing Escherichia coli in cattle effluents and environment: an updated review. Vet Microbiol 132: 1-18.
4. Brooks JT, Sowers EG, Wells JG, Greene KD, Griffin PM, et al. (2005) Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis 192: 1422-1429.
5. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, et al. (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37: 497-503.
6. Endo Y, Tsurugi K, (1988) The RNA N-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA. J Biol Chem 263: 8735-8739.
7. Khine AA, Lingwood CA, (1994) Capping and receptor-mediated endocytosis of cell-bound verotoxin (Shiga-like toxin). 1: Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization. J Cell Physiol 161: 319-332.
8. Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, et al. (1989) Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157: H7 infections. J Infect Dis 160: 994-998.
9. Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, et al. (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185: 74-84.
10. Fuller CA, Pellino CA, Flagler MJ, Strasser JE, Weiss AA, (2011) Shiga toxin subtypes display dramatic differences in potency. Infect Immun 79: 1329-1337.
11. Tesh VL, Burris JA, Owens JW, Gordon VM, Wadolkowski EA, et al. (1993) Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61: 3392-3402.
12. Scheutz F, Teel LD, Beutin L, Pierard D, Buvens G, et al. (2012) Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol 50: 2951-2963.
13. Sonntag AK, Bielaszewska M, Mellmann A, Dierksen N, Schierack P, et al. (2005) Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells. Appl Environ Microbiol 71: 8855-8863.
14. Persson S, Olsen KE, Ethelberg S, Scheutz F, (2007) Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol 45: 2020-2024.
15. Ojeda A, Prado V, Martinez J, Arellano C, Borczyk A, et al. (1995) Sorbitol-negative phenotype among enterohemorrhagic Escherichia coli strains of different serotypes and from different sources. J Clin Microbiol 33: 2199-2201.
16. March SB, Ratnam S, (1986) Sorbitol-MacConkey medium for detection of Escherichia coli O157: H7 associated with hemorrhagic colitis. J Clin Microbiol 23: 869-872.
17. Hoffmann S, Batz MB, Morris JG Jr, (2012) Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot 75: 1292-1302.
18. Caprioli A, Luzzi I, Rosmini F, Resti C, Edefonti A, et al. (1994) Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J Infect Dis 169: 208-211.
19. Starr M, Bennett-Wood V, Bigham AK, de Koning-Ward TF, Bordun AM, et al. (1998) Hemolytic-uremic syndrome following urinary tract infection with enterohemorrhagic Escherichia coli: case report and review. Clin Infect Dis 27: 310-315.
20. Fey PD, Wickert RS, Rupp ME, Safranek TJ, Hinrichs SH, (2000) Prevalence of non-O157: H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 6: 530-533.
21. Klein EJ, Stapp JR, Clausen CR, Boster DR, Wells JG, et al. (2002) Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 141: 172-177.
22. Willford J, Mills K, Goodridge LD, (2009) Evaluation of three commercially available enzyme-linked immunosorbent assay kits for detection of Shiga toxin. J Food Prot 72: 741-747.
23. CDC (2001) University outbreak of calicivirus infection mistakenly attributed to Shiga toxin-producing Escherichia coli O157: H7- Virginia, 2000. MMWR Morb Mortal Wkly Rep 50: 489-491.
24. He X, Quinones B, McMahon S, Mandrell RE, (2012) A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli. Toxins (Basel) 4: 487-504.
25. He X, Qi W, Quiñones B, McMahon S, Cooley M, et al. (2011) Sensitive detection of Shiga Toxin 2 and some of its variants in environmental samples by a novel immuno-PCR assay. Appl Environ Microbiol 77: 3558-3564.
26. He X, McMahon S, Skinner C, Merrill P, Scotcher MC, et al. (2012) Development and characterization of monoclonal antibodies against Shiga toxin 2 and their application for toxin detection in milk. J Immunol Methods.
27. Cooley M, Carychao D, Crawford-Miksza L, Jay MT, Myers C, et al. (2007) Incidence and tracking of Escherichia coli O157: H7 in a major produce production region in California. PLoS ONE 2: e1159.
28. Donohue-Rolfe A, Kondova I, Oswald S, Hutto D, Tzipori S, (2000) Escherichia coli O157: H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2. J Infect Dis 181: 1825-1829.
29. Stanker LH, Merrill P, Scotcher MC, Cheng LW, (2008) Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type A and their use in analysis of milk by sandwich ELISA. J Immunol Methods 336: 1-8.